These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28796030)

  • 1. The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study.
    Ma H; Liu Y; Xie H; Zhang G; Zhan H; Liu Z; Wang P; Geng Q; Guo L
    Medicine (Baltimore); 2017 Aug; 96(32):e7351. PubMed ID: 28796030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
    Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
    JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Shehata M; Hamza M
    Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention.
    Otsuka K; Shimada K; Katayama H; Nakamura H; Ishikawa H; Takeda H; Fujimoto K; Kasayuki N; Yoshiyama M
    Heart Vessels; 2019 May; 34(5):735-744. PubMed ID: 30386919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
    Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
    Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
    Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of kidney function on patient survival after percutaneous coronary intervention for acute coronary syndrome in left main coronary artery disease.
    Balevski I; Burja S; Petreski T; Piko N; Arva V; Kanič V; Bevc S
    Clin Nephrol; 2021 Suppl; 96(1):1-5. PubMed ID: 34643484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognosis of percutaneous coronary intervention-associated nephropathy in patients with acute coronary syndrome and normal kidney function.
    Hernando L; Canovas E; Freites A; de la Rosa A; Alonso J; del Castillo R; Salinas P; Montalvo GB; Huelmos AI; Botas J
    Rev Esp Cardiol (Engl Ed); 2015 Apr; 68(4):310-6. PubMed ID: 25263104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of statin therapy on renal function and long-term prognosis in acute coronary syndrome patients with chronic kidney disease.
    Shibui T; Nakagomi A; Kusama Y; Atarashi H; Mizuno K
    Int Heart J; 2010; 51(5):312-8. PubMed ID: 20966602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute kidney injury requiring dialysis and in-hospital mortality in patients with chronic kidney disease and non-ST-segment elevation acute coronary syndrome undergoing early vs delayed percutaneous coronary intervention: A nationwide analysis.
    Patel B; Carson P; Shah M; Garg L; Agarwal M; Agrawal S; Arora S; Steigerwalt S; Bavry A; Dusaj R; Patel N; Feldman B
    Clin Cardiol; 2017 Dec; 40(12):1303-1308. PubMed ID: 29266282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.
    Watabe H; Sato A; Hoshi T; Takeyasu N; Abe D; Akiyama D; Kakefuda Y; Nishina H; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Jun; 174(1):57-63. PubMed ID: 24726211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.
    Abbasi SH; Mohammadinejad P; Shahmansouri N; Salehiomran A; Beglar AA; Zeinoddini A; Forghani S; Akhondzadeh S
    J Affect Disord; 2015 Sep; 183():149-55. PubMed ID: 26005776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
    Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
    Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and renal outcomes following percutaneous coronary intervention in a population with renal disease: a case-control study.
    Allen LA; Pyart RD; Holmes J; Donovan KL; Anderson RA; Phillips AO
    QJM; 2019 Sep; 112(9):669-674. PubMed ID: 31161203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ
    Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    Berwanger O; Santucci EV; de Barros E Silva PGM; Jesuíno IA; Damiani LP; Barbosa LM; Santos RHN; Laranjeira LN; Egydio FM; Borges de Oliveira JA; Dall Orto FTC; Beraldo de Andrade P; Bienert IRC; Bosso CE; Mangione JA; Polanczyk CA; Sousa AGMR; Kalil RAK; Santos LM; Sposito AC; Rech RL; Sousa ACS; Baldissera F; Nascimento BR; Giraldez RRCV; Cavalcanti AB; Pereira SB; Mattos LA; Armaganijan LV; Guimarães HP; Sousa JEMR; Alexander JH; Granger CB; Lopes RD;
    JAMA; 2018 Apr; 319(13):1331-1340. PubMed ID: 29525821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.
    Azzalini L; Poletti E; Lombardo F; Laricchia A; Beneduce A; Moscardelli S; Bellini B; Maccagni D; Cappelletti A; Ancona MB; Carlino M; Chieffo A; Colombo A; Montorfano M
    Int J Cardiol; 2019 Sep; 290():59-63. PubMed ID: 31005417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.